Avivagen Inc. announced the appointment of Mr. Ira Levy as interim CFO, effective immediately. Mr. Levy has over 15 years of experience in a wide range of high-growth, early-stage companies, both public and private, with an MBA from the Schulich School of Business in addition to his professional designation as a Chartered Accountant.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% |
|
0.00% | 0.00% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 284K | |
+4.54% | 10.61B | |
-0.75% | 5.72B | |
+17.86% | 5.18B | |
+1.49% | 5.03B | |
-33.39% | 2.26B | |
+1.63% | 1.88B | |
-27.60% | 1.05B | |
+44.67% | 1.01B | |
-27.61% | 835M |
- Stock Market
- Equities
- VIV.H Stock
- News Avivagen Inc.
- Avivagen Inc. Appoints Ira Levy as Interim CFO